Navigation Links
Cadence Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences
Date:4/27/2009

SAN DIEGO, April 27 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX) announced today that data from clinical trials of its investigational product candidate, Acetavance(TM) (intravenous acetaminophen), will be presented at the American Society of Regional Anesthesia and Pain Medicine (ASRA) 34th Annual Regional Anesthesia Meeting in Phoenix, Arizona on April 30, 2009 and at the Society of Hospital Medicine (SHM) Annual Meeting in Chicago, Illinois on May 16, 2009.

At the ASRA meeting, data from three completed clinical trials of Acetavance will be presented in poster presentations, as follows:

  • "A Phase III, Multi-Center, Randomized, Double-blind, Placebo-Controlled 24 Hour Study of the Efficacy and Safety of Intravenous Acetaminophen in Abdominal Laparoscopic Surgery" (Study 304; abstract number 97)
  • "A Phase III, Multicenter, Open-label, Prospective, Repeated Dose, Multi Day Randomized Controlled Study of the Safety of IV Acetaminophen in Adults" (Study 351; abstract number 96)
  • "Pediatric Safety of Repeated Doses of IV Acetaminophen" (Study 352; abstract number 58)

Data from two other completed clinical trials of Acetavance will be presented in poster presentations at the SHM meeting, as follows:

  • "Randomized Study of the Efficacy and Safety of IV Acetaminophen Compared to Placebo for the Treatment of Fever" (Study 302; abstract number 85)
  • "Randomized Study of the Efficacy and Safety of IV Acetaminophen Compared to Oral Acetaminophen for the Treatment of Fever" (Study 303; abstract number 84)

Top line data from each of these clinical trials has been previously disclosed by Cadence, with the exception of data fro
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at BioCentury Publications Inc. Future Leaders in the Biotech Industry Conference in New York on April 2, 2009
2. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2008 Financial Results and Corporate Update on March 12, 2009
3. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference
4. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and Provide a Clinical Program Update on November 6, 2008
5. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the BIOCOM Investor Conference
6. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the JMP Securities Third Annual Healthcare Focus Conference
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the 2008 NewsMakers In the Biotech Industry Conference
8. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Two Investment Conferences During the Month of August 2008
9. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Leerink Swann Pain Roundtable Conference on June 23, 2008 in New York
10. Cadence Pharmaceuticals CEO Ted Schroeder to Present at Three Investment Conferences During the Month of May 2008
11. Cadence Pharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference on March 20, 2008 in Boston
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Iowa , Sept. 30, 2014  KemPharm, ... the discovery and development of proprietary new molecular ... States Patent and Trademark Office (USPTO) issued U.S. ... application entitled, "Benzoic Acid, Benzoic Acid Derivatives and ... of Making and Use Thereof." The ...
(Date:9/30/2014)... Sept. 30, 2014 FemCap Inc., www.femcap.com ... its receipt of a patent No: US, 8,795,248 B2 ... also received FDA clearance in the U.S., 510(K) K121857, ... in Europe. This patent is related to its menstrual cup ... the company is releasing FemmyCycle Teen, a third menstrual ...
(Date:9/30/2014)... LONDON , Sept. 30, 2014 ... analyze global next-generation (NGS) sequencing trends and use. ... technology use is expected to increase within the ... are the top criteria for purchasing sequencing instruments. ... technologies. The popularity of RNA-Seq continues to surge, ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Lyme ... funder of Lyme disease research at universities, today announced ... focused on the identification, treatment and cure for Lyme ... had received the most applications in its history—over 20 ... , “While we were pleased to receive so many ...
Breaking Biology Technology:KemPharm, Inc. Receives Patent from the USPTO for Novel Prodrug of Hydromorphone, KP511 2The FemmyCycle 2Global Next-generation Sequencing Trends 2Lyme Research Alliance Awards Nearly $600,000 in New Grants 2Lyme Research Alliance Awards Nearly $600,000 in New Grants 3Lyme Research Alliance Awards Nearly $600,000 in New Grants 4
... ), focused on discovering, developing and,commercializing treatments for diabetes and ... -- 18th Annual Wachovia Nantucket Equity Conference on Monday, ... (Eastern Time) at The White Elephant in Nantucket ... Conference on Thursday, June 26, 2008 ...
... and Advance,Healthcare, WASHINGTON, June 16 The ... Act (HIPAA) is having a,negative impact on the ... that benefit society, says a newly-released report by ... Barriers to,Research and Discovery describes the unintended disruptive ...
... ROCKVILLE, Md., June 16 Novavax, Inc.,(Nasdaq: NVAX ... Singhvi, President and Chief Executive Officer, will be presenting ... on June 24, 2008 at,The ANdAZ Hotel in London, ... strategy, research and development progress. A link to the ...
Cached Biology Technology:HIPAA Privacy Rule Impedes Biomedical Research 2
(Date:9/30/2014)... Fish can live in almost any aquatic environment on ... up many species are pushed to the limit. The ... could prove critical for how different species cope in ... the University of Gothenburg, published in the scientific journal ... Climate change continues apace thanks to increasing levels of ...
(Date:9/30/2014)... it comes to using marijuana, new research, involving mice ... Journal of Leukocyte Biology , suggests ... that you should. That,s because a team of Italian ... do serious long-term damage to the immune system. This ... diseases, such as multiple sclerosis, inflammatory bowel disease and ...
(Date:9/30/2014)... trouble getting pregnanteven with IVF? Here,s some hope: A ... The FASEB Journal , explains how ... known as PAWP, which induced embryo development in human ... embryo development by the sperm cell during fertilization. , ... a major paradigm shift in our understanding of human ...
Breaking Biology News(10 mins):Shape up quickly -- applies to fish, too! 2Adolescent exposure to thc may cause immune systems to go up in smoke 2Synthetic sperm protein raises the chance for successful in vitro fertilization 2
... and terrorist attacks may bring about profound spiritual ... for people that have experienced or witnessed these ... mental disorder caused by psychological trauma is termed ... damage alter as symptoms improve? As PTSD progresses, ...
... just published research that will help you every morning ... Vice-Chancellor will allow oceanographers and meteorologists to better predict ... as they travel across the globe. "Ocean cargo ... activities such as surfing, are all dependent on wave ...
... recently awarded a $449,641 grant by the Institute of Museum ... crowd sourcing and gaming to support the enhancement of texts ... December 2013 and ends in December 2015. The Garden will ... Botanical Garden on the project. , The BHL is ...
Cached Biology News:VC predicts the motion of the ocean 2Missouri Botanical Garden aims to improve access to digital texts through online gaming 2
100 g monoclonal antibody which can immunocapture ~10 g of Complex IV from heart mitochondria. Also included are 2 mg of bovine heart mitochondria for control immunocapture....
Rabbit polyclonal to GPR56 ( Abpromise for all tested applications). entrezGeneID: 9289 SwissProtID: Q9Y653...
...
Tube-O-DIALYZER Floats, small....
Biology Products: